Filed: 8/14/2023ACC: 0001012975-23-000341
📋 What this filing means
EUCLIDEAN CAPITAL LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $389.14M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$389.14M
Total AUM (reported)
22.35M
Total Shares
Allocation by class
TR UNIT$109.16M28.1%
MSCI INDIA ETF$105.98M27.2%
GOLD SHS$98.94M25.4%
COM$57.14M14.7%
CLASS A COM$17.93M4.6%
Portfolio Concentration
Top 3$314.08M80.7%
4–10$72.69M18.7%
11–25$2.38M0.6%
Top 3 weight
80.7%
Top 10 weight
99.4%
Voting Authority Distribution
Total shares with voting rights: 22.35M
Sole
Full voting authority
22.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
SPDR S&P 500 ETF TR
SOLEShares246.25K
TypeSH
Market value$109.16M
28.05%
Sole
246.25K
Shared
0.00
None
0.00
ISHARES TR
SOLEShares2.43M
TypeSH
Market value$105.98M
27.23%
Sole
2.43M
Shared
0.00
None
0.00
SPDR GOLD TR
SOLEShares555K
TypeSH
Market value$98.94M
25.43%
Sole
555K
Shared
0.00
None
0.00
23ANDME HOLDING CO
SOLEShares10.24M
TypeSH
Market value$17.93M
4.61%
Sole
10.24M
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares2.55M
TypeSH
Market value$15.93M
4.09%
Sole
2.55M
Shared
0.00
None
0.00
FOGHORN THERAPEUTICS INC
SOLEShares1.57M
TypeSH
Market value$11.08M
2.85%
Sole
1.57M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares571.23K
TypeSH
Market value$10.68M
2.75%
Sole
571.23K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares980.89K
TypeSH
Market value$5.90M
1.51%
Sole
980.89K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares747.55K
TypeSH
Market value$5.80M
1.49%
Sole
747.55K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares915.71K
TypeSH
Market value$5.38M
1.38%
Sole
915.71K
Shared
0.00
None
0.00
NGM BIOPHARMACEUTICALS INC
SOLEShares746.67K
TypeSH
Market value$1.93M
0.50%
Sole
746.67K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares802.96K
TypeSH
Market value$441.6K
0.11%
Sole
802.96K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 246.25K | SH | $109.16M 28.05% | 246.25K | 0.00 | 0.00 |
ISHARES TRSOLE | MSCI INDIA ETF | 2.43M | SH | $105.98M 27.23% | 2.43M | 0.00 | 0.00 |
SPDR GOLD TRSOLE | GOLD SHS | 555K | SH | $98.94M 25.43% | 555K | 0.00 | 0.00 |
23ANDME HOLDING COSOLE | CLASS A COM | 10.24M | SH | $17.93M 4.61% | 10.24M | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 2.55M | SH | $15.93M 4.09% | 2.55M | 0.00 | 0.00 |
FOGHORN THERAPEUTICS INCSOLE | COM | 1.57M | SH | $11.08M 2.85% | 1.57M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 571.23K | SH | $10.68M 2.75% | 571.23K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 980.89K | SH | $5.90M 1.51% | 980.89K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 747.55K | SH | $5.80M 1.49% | 747.55K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 915.71K | SH | $5.38M 1.38% | 915.71K | 0.00 | 0.00 |
NGM BIOPHARMACEUTICALS INCSOLE | COM | 746.67K | SH | $1.93M 0.50% | 746.67K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM | 802.96K | SH | $441.6K 0.11% | 802.96K | 0.00 | 0.00 |